A burning sensation in the feet is usually harmless and temporary; however if it is chronic it can be due to various ...

New guidelines from the American College of Cardiology and American Heart Association update best practices for managing peripheral artery disease (PAD). The comprehensive clinical guidelines synopsis ...

According to the National Heart, Lung, and Blood Institute, nearly 10 million people aged 40 and older have Peripheral Artery ...

Semaglutide was associated with improved maximum walking distance across type 2 diabetes subgroups among patients with ...

A “slow developing” symptom in the feet could be a warning sign of high cholesterol and even heart disease. This lesser-known ...

A post-hoc analysis of STRIDE confirms the benefit of GLP-1 RA in patients with peripheral arterial disease and type 2 ...

Semaglutide 1 mg improves walking distance in patients with early peripheral artery disease and type 2 diabetes, regardless ...

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and ...

Global Peripheral Artery Disease Market is valued at approximately USD 4.5 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.7% over the forecast period 2024-2032.